JGC
IOVA icon

J. Goldman & Co’s Iovance Biotherapeutics IOVA Stock Holding History

J. Goldman & Co’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– – – 551
2024
Q1 		– Hold
0
– – – 497
2023
Q4 		– Sell
-13,500
Closed -$61.4K – 436
2023
Q3 		$61.4K Buy
+13,500
New +$88.1K ﹤0.01% 337
2023
Q2 		– Sell
-651,664
Closed -$3.98M – 472
2023
Q1 		$3.98M Buy
+651,664
New +$4.5M 0.23% 163
2021
Q1 		– Hold
0
– – – 500
2020
Q4 		– Hold
0
– – – 445
2020
Q2 		– Sell
-45,205
Closed -$1.35M – 312
2020
Q1 		$1.35M Buy
+45,205
New +$1.2M 0.24% 126

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return